Cerevance Appoints Ottavio V. Vitolo, M.D., as Chief Medical Officer
as chief medical officer.
- as chief medical officer.
- We are thrilled to welcome Ottavio whose expertise will help advance our broad portfolio of innovative treatments for neurodegenerative diseases, said Craig Thompson, chief executive officer of Cerevance.
- Dr. Vitolo most recently served as chief medical officer and global head of R&D at Alcyone Therapeutics.
- Prior to this position, Dr. Vitolo served as senior vice president, head of R&D and chief medical officer at Relmada Therapeutics Inc.